Vitamin D receptor expression in plasmablastic lymphoma and myeloma cells confers susceptibility to vitamin D
Plasmablastic B-cell malignancies include plasmablastic lymphoma and subsets of multiple myeloma and diffuse large B-cell lymphoma (DLBCL). These diseases can be difficult to diagnose and treat, and lack well-characterised cell line models. Here, immunophenotyping and FOXP1 expression profiling identified plasmablastic characteristics in DLBCL cell lines HLY-1 and SU-DHL-9, associated with CTNNAL1, HPGD, RORα, IGF1 and/or vitamin D receptor (VDR) transcription. We demonstrated VDR protein exp...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Pubs id:
- Local pid:
- Deposit date:
- Copyright holder:
- Endocrine Society
- Copyright date:
Copyright © 2017 by the Endocrine Society.
This article is published under the terms of the Creative Commons Attribution-Non
Commercial License (CC-BY-NC; https://creativecommons.org/licenses/by-nc/4.0/).
If you are the owner of this record, you can report an update to it here: Report update to this record